Effectiveness of Trastuzumab in First-Line HER2+ Metastatic Breast Cancer After Failure in Adjuvant Setting: A Controlled Cohort Study

BACKGROUND. The evidence supporting the use of trastuzumab (T) in a metastatic setting comes from studies that included (almost) only patients who never received prior T. We investigated the effectiveness of T as first-line therapy for metastatic breast cancer (mBC) in women previously treated with...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Oncologist
Main Authors: Negri, Eva, Zambelli, Alberto, Franchi, Matteo, Rossi, Marta, Bonifazi, Martina, Corrao, Giovanni, Moja, Lorenzo, Zocchetti, Carlo, La Vecchia, Carlo
פורמט: Artigo
שפה:Inglês
יצא לאור: AlphaMed Press 2014
נושאים:
Breast Cancer
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4257745/
https://ncbi.nlm.nih.gov/pubmed/25355843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0227
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים